AGA Medical Corporation
ProductsKurt Amplatz Center for EducationAbout AGAClinical TrialsNews

Leading the Way in Structural Heart Disease Treatment and New Solutions for Vascular Conditions

AGA Medical pioneered the repair of congenital and structural heart defects using non-surgical techniques for treating a wide range of these life threatening diseases.

Atrial Septal Defects

Atrial Septal Defects (ASD) are caused by incomplete growth of the tissue wall (septum) that separates the upper chambers of the heart (atria).

Ventricular Septal Defects

Ventricular Septal Defects (VSD) are caused by incomplete growth of the tissue wall (septum) that separates the lower chambers of the heart (ventricles).

Vascular Occlusion

Blood vessel occlusion (closure) may be used to reduce or eliminate blood flow to a targeted organ, or to reroute blood flow through other vessels.

Current Clinical Trials

Respect Logo Respect Trial - United States
AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.
Premium Premium Trial - United States
AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.

AGA News

Kurt Amplatz Center for Education

Tedy Bruschi